November 2019 FDA Recall Vancomycin Hydrochloride by Auromedics Pharma Llc
D-0574-2020 - Discoloration

This Class II drug recall was voluntarily initiated by Auromedics Pharma Llc on November 25, 2019 for the product Vancomycin Hydrochloride. The FDA reported the reason for recall as discoloration. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0574-2020

Reason for Recall
Discoloration: Product complaints of discoloration after reconstitution of vials.
Initiated
11-25-2019
Reported
12-18-2019
Quantity
275,060 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
AuroMedics Pharma LLC
Nationwide in the USA
Vancomycin Hydrochloride for Injection, USP, 1 g* per vial, packaged in 10-count vials per carton, Rx only, Mft. in India for: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-204-20.

Batch or Lot Expiration Information

Lot# : CVM180003, CVM180004, Exp 04/2020; CVM180008, Exp 07/2020; CVM180009, CVM180010, CVM180011, CVM180012, Exp 09/2020